• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆症和阿尔茨海默病的动物模型用于临床前测试和临床转化。

The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation.

机构信息

Department of Neurology, Post Graduate institute of Medical Education and Research, Chandigarh, India.

出版信息

Curr Alzheimer Res. 2012 Nov;9(9):1010-29. doi: 10.2174/156720512803569055.

DOI:10.2174/156720512803569055
PMID:22698073
Abstract

Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease. The various strategies to treat dementia need validation of novel compounds in suitable animal models for testing their safety and efficacy. These may include novel anti-amnesic drugs derived from synthetic chemistry or those derived from traditional herbal sources. Multiple approaches have been adopted to create reliable animal models ranging from rodents to non-human primates, where the animals are exposed to a predetermined injury or causing genetic ablation across specific regions of brain suspected to affect learning functions. In this review various animal models for Alzheimer's disease and treatment strategies in development of anti dementia drugs are discussed and an attempt has been made to provide a comprehensive report of the latest developments in the field.

摘要

痴呆是一种以记忆丧失程度异常和回忆过去事件的能力受损为特征的临床综合征,通常以阿尔茨海默病为代表。治疗痴呆的各种策略需要在合适的动物模型中验证新型化合物,以测试其安全性和疗效。这些化合物可能包括源自合成化学的新型抗健忘药物或源自传统草药来源的药物。已经采用了多种方法来创建可靠的动物模型,从啮齿动物到非人类灵长类动物,这些动物暴露于预定的损伤或导致大脑特定区域的遗传消融,这些区域被怀疑影响学习功能。在这篇综述中,讨论了用于阿尔茨海默病的各种动物模型和开发抗痴呆药物的治疗策略,并试图提供该领域最新发展的综合报告。

相似文献

1
The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation.痴呆症和阿尔茨海默病的动物模型用于临床前测试和临床转化。
Curr Alzheimer Res. 2012 Nov;9(9):1010-29. doi: 10.2174/156720512803569055.
2
Alzheimer's disease in the zebrafish: where can we take it?斑马鱼中的阿尔茨海默病:我们能将其研究到什么程度?
Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):179-186. doi: 10.1097/FBP.0000000000000284.
3
Animal models in the drug discovery pipeline for Alzheimer's disease.用于阿尔茨海默病药物发现的动物模型。
Br J Pharmacol. 2011 Oct;164(4):1285-300. doi: 10.1111/j.1476-5381.2011.01299.x.
4
Role of σ Receptors in Learning and Memory and Alzheimer's Disease-Type Dementia.σ受体在学习记忆及阿尔茨海默病型痴呆中的作用。
Adv Exp Med Biol. 2017;964:213-233. doi: 10.1007/978-3-319-50174-1_15.
5
Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy.犬类认知功能障碍作为人类年龄相关性认知衰退、痴呆和阿尔茨海默病的模型:临床表现、认知测试、病理学及对司来吉兰治疗的反应
Prog Brain Res. 1995;106:217-25. doi: 10.1016/s0079-6123(08)61218-2.
6
Memantine for dementia.美金刚用于治疗痴呆症。
Cochrane Database Syst Rev. 2003(1):CD003154. doi: 10.1002/14651858.CD003154.
7
Memantine for dementia.美金刚用于治疗痴呆症。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD003154. doi: 10.1002/14651858.CD003154.pub2.
8
Animal models of dementia and cognitive dysfunction.痴呆和认知功能障碍的动物模型。
Life Sci. 2014 Jul 30;109(2):73-86. doi: 10.1016/j.lfs.2014.05.017. Epub 2014 Jun 2.
9
Memantine: pharmacological properties and clinical uses.美金刚:药理特性与临床应用
Neurol India. 2004 Sep;52(3):307-9.
10
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.阿尔茨海默病及其他神经退行性疾病所致痴呆——美金刚,新希望。
Pharmacol Res. 2005 Jan;51(1):1-17. doi: 10.1016/j.phrs.2004.05.005.

引用本文的文献

1
Stem cell therapy use in patients with dementia: a systematic review.干细胞疗法在痴呆患者中的应用:一项系统综述。
Int J Emerg Med. 2025 May 12;18(1):95. doi: 10.1186/s12245-025-00876-6.
2
Integrative Approach to COVID-19: An Indian Facebook Recipe for Mental Health.应对新冠疫情的综合方法:印度脸书上的心理健康秘诀
Ann Neurosci. 2021 Jul;28(3-4):183-190. doi: 10.1177/09727531211052971. Epub 2022 Jan 7.
3
An fMRI Study Using a Combined Task of Interval Discrimination and Oddball Could Reveal Common Brain Circuits of Cognitive Change.
一项使用间隔辨别与异常刺激组合任务的功能磁共振成像研究可能揭示认知变化的共同脑回路。
Front Psychiatry. 2021 Dec 20;12:786113. doi: 10.3389/fpsyt.2021.786113. eCollection 2021.
4
Management of Type II Diabetes by Modulating the Modifiable Risk Factors: A Future Roadmap for Prevention of Cerebrovascular Complications.通过调节可改变的风险因素管理2型糖尿病:预防脑血管并发症的未来路线图。
Ann Neurosci. 2020 Jul;27(3-4):266-272. doi: 10.1177/09727531211000041. Epub 2021 May 28.
5
Ayurveda Body-Mind Constitutional Types and Role of Yoga Intervention Among Type 2 Diabetes Mellitus Population of Chandigarh and Panchkula Regions.阿育吠陀身心体质类型以及瑜伽干预在昌迪加尔和潘切库拉地区2型糖尿病患者群体中的作用。
Ann Neurosci. 2020 Jul;27(3-4):214-223. doi: 10.1177/09727531211000040. Epub 2021 Jun 4.
6
Depression in High-Risk Type 2 Diabetes Adults.高危2型糖尿病成年患者的抑郁症
Ann Neurosci. 2020 Jul;27(3-4):204-213. doi: 10.1177/0972753121990181. Epub 2021 Aug 26.
7
Physical Activity Patterns in India Stratified by Zones, Age, Region, BMI and Implications for COVID-19: A Nationwide Study.印度按地区、年龄、区域、体重指数分层的身体活动模式及其对COVID-19的影响:一项全国性研究。
Ann Neurosci. 2020 Jul;27(3-4):193-203. doi: 10.1177/0972753121998507. Epub 2021 May 12.
8
Sleep Disorders in Individuals With High Risk for Diabetes in Indian Population.印度人群中糖尿病高危个体的睡眠障碍
Ann Neurosci. 2020 Jul;27(3-4):183-189. doi: 10.1177/0972753121998470. Epub 2021 Apr 24.
9
Trends of Hypertension and Neurological Diseases in India: A Nationwide Survey Reporting the Distribution Across Geographical Areas.印度高血压与神经系统疾病的趋势:一项报告地理区域分布情况的全国性调查
Ann Neurosci. 2020 Jul;27(3-4):162-168. doi: 10.1177/0972753120987457. Epub 2021 May 12.
10
Prevalence of Obesity in India and Its Neurological Implications: A Multifactor Analysis of a Nationwide Cross-Sectional Study.印度肥胖症的患病率及其神经学影响:一项全国性横断面研究的多因素分析
Ann Neurosci. 2020 Jul;27(3-4):153-161. doi: 10.1177/0972753120987465. Epub 2021 May 29.